Is Canopy Growth (TSX:WEED) the Best Growth Stock to Buy in 2022?

With Canopy Growth stock trading down by roughly 85% from its 52-week high, is it the best Canadian growth stock to buy in 2022?

| More on:
edit Jars of marijuana

Image source: Getty Images

Leading up to legalization, investors were excited about the potential that the cannabis market would offer. However, despite years of legalization now, many of these companies in the industry, including one of the industry leaders, Canopy Growth (TSX:WEED)(NASDAQ:CGC), have struggled to turn a profit. But as the industry continues to consolidate, and WEED stock trades mighty cheap right now, is Canopy the best growth stock to buy for 2022?

While the legalization of cannabis offered a tonne of opportunity, and it’s certainly helped the government to collect more tax dollars, the amount of competition in the industry has made it difficult for any company to excel. This was apparent as soon as legalization took place, especially as the industry faced tough competition from the black market for years.

But with WEED stock now trading exceptionally cheap, is it the best Canadian growth stock to buy in 2022?

Is WEED stock worth an investment?

As of last Friday’s close, WEED stock traded for $10.78, slightly above its 52-week low of $10.18 and roughly 85% off its 52-week high of $70 a share. So, this goes to show how cheap the stock is today. However, that doesn’t automatically make it the best growth stock to buy in 2022.

At $10.78, the company still has a market cap of more than $4.2 billion. Meanwhile, over the last 12 months, WEED stock has managed to do just over $550 million in sales. And while sales have almost doubled over the last two years, Canopy hasn’t come anywhere close to earning a profit yet.

So, right now, WEED stock trades at a price-to-sales ratio of 7.5 times while still being nowhere near breaking even. Therefore, I’d have to say Canopy Growth stock is still considerably overvalued and a higher-risk investment.

While I believe in the company’s potential over the long run, the price of the shares today compared to what it’s been able to accomplish so far, in my opinion, makes it far too risky.

It’s worth noting that analysts expect roughly 25% growth in sales over each of the next three years, bringing Canopy Growth’s sales in 2025 to $1.15 billion. However, even then, at Canopy’s current price, it would have a price-to-sales ratio of almost four times. In addition, by 2025, according to estimates, WEED stock still won’t be turning a profit.

So, if you’re looking for one of the best Canadian growth stocks to buy in 2022, you may have to look elsewhere.

The best Canadian growth stock to buy in 2022

There are several high-potential Canadian stocks to buy in 2022, but in my opinion, considering the risk to reward, Brookfield Infrastructure Partners (TSX:BIP.UN)(NYSE:BIP) is the best growth stock to buy this year.

There is a lot of uncertainty these days, which already makes finding the right investments difficult. It’s also why taking a position in an expensive and unprofitable stock like WEED may not be the best investment.

Instead, an extremely reliable company with highly defensive assets such as Brookfield looks like an excellent stock to buy and hold through 2022 and beyond. The fact that it’s so reliable and its infrastructure assets are highly defensive is a major factor why, but in addition, the assets are also diversified worldwide, which in this economic environment can be very important.

Often, though, when you want to buy a defensive investment, you compromise on the growth potential. With Brookfield, that shouldn’t be the case. It has an incredible management team and invests your capital with a long-term mindset, targeting up to 15% annual gains.

So, if you’re looking for one of the best Canadian growth stocks to buy in 2022, at least in this economic environment, Brookfield looks like a far better investment than Canopy Growth.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Daniel Da Costa owns Brookfield Infra Partners LP Units. The Motley Fool recommends Brookfield Infra Partners LP Units.

More on Cannabis Stocks

Cannabis stocks have fallen.
Cannabis Stocks

Why Tilray Will Be the First Cannabis Stock to Bounce Back

Tilray is down 38% year to date, but it's one of the only profitable cannabis companies out there.

Read more »

Pot stocks
Cannabis Stocks

Canopy Growth: What Went Wrong?

Before cannabis was legalized in Canada, this stock was soaring, as was its public profile.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Is Cronos Group (TSX:CRON) a Buy After its 1st-Quarter Performance?

Cronos Group remains a high-risk, high-reward stock, despite its solid first-quarter performance.

Read more »

Cannabis smoke
Cannabis Stocks

Aurora Cannabis Stock Hits 52-Week Low: What Investors Should Know

Aurora Cannabis stock continues to fall, hitting a yearly bottom last week. So what should investors do now?

Read more »

edit Jars of marijuana
Cannabis Stocks

Here’s Why Curaleaf Is a Better Cannabis Stock Compared to Sundial!

Cannabis giant Curaleaf ended 2021 with $1.2 billion in sales, making it one of the largest marijuana companies in the…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

2 Cannabis Stocks Better Than Sundial Growers

Here's why Green Thumb Industries and Cresco Labs are much better long-term bets compared to Sundial Growers.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Hexo Stock Jumps 10% on Definitive Tilray Deal

Hexo (TSX:HEXO)(NASDAQ:HEXO) stock jumped 10% on Monday, as its deal with Tilray (TSX:TLRY)(NASDAQ:TLRY) stock became official.

Read more »

edit Jars of marijuana
Cannabis Stocks

Down 97% From Record Highs, Is Sundial Stock a Buy Right Now?

Despite the 97% decline in Sundial stock from its record high, it remains a risky bet for long-term investors due…

Read more »